| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,540,000 |
| Market
Cap: |
346.61(M) |
| Last
Volume: |
34,905,322 |
Avg
Vol: |
12,324,947 |
| 52
Week Range: |
$4.1 - $4.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scheinberg David A |
Director |
– • – |
2008-03-28 |
4 |
OE |
$3.52 |
$35,093 |
D/D |
7,500 |
46,185 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-03-03 |
4 |
AS |
$15.30 |
$15,300 |
D/D |
(1,000) |
35,879 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-03-03 |
4 |
OE |
$12.29 |
$12,290 |
D/D |
1,000 |
36,879 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-02-01 |
4 |
AS |
$16.44 |
$16,440 |
D/D |
(1,000) |
35,879 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-02-01 |
4 |
OE |
$12.29 |
$12,290 |
D/D |
1,000 |
36,879 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$9,358 |
D/D |
(519) |
32,868 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$8,738 |
D/D |
570 |
33,387 |
|
- |
|
| Baker Mark Robert |
General Counsel |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$15,037 |
D/D |
(834) |
25,020 |
|
- |
|
| Baker Mark Robert |
General Counsel |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$14,042 |
D/D |
916 |
25,854 |
|
- |
|
| Mckinney Robert A |
Chief Financial Officer |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$11,359 |
D/D |
(630) |
33,571 |
|
- |
|
| Mckinney Robert A |
Chief Financial Officer |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$10,608 |
D/D |
692 |
34,201 |
|
- |
|
| Kremer Alton B |
VP, Clinical Research |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$18,679 |
D/D |
(1,036) |
29,849 |
|
- |
|
| Kremer Alton B |
VP, Clinical Research |
• – – |
2008-01-02 |
4 |
OE |
$15.36 |
$17,495 |
D/D |
1,139 |
30,885 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-01-02 |
4 |
AS |
$18.12 |
$18,120 |
D/D |
(1,000) |
35,879 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-01-02 |
4 |
OE |
$12.29 |
$27,267 |
D/D |
1,977 |
36,879 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$16,029 |
D/D |
(889) |
35,879 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$11,359 |
D/D |
(630) |
36,564 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$10,608 |
D/D |
692 |
37,194 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-12-06 |
4 |
AS |
$20.00 |
$20,000 |
D/D |
(1,000) |
35,730 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-12-06 |
4 |
OE |
$13.75 |
$13,750 |
D/D |
1,000 |
36,730 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-12-03 |
4 |
AS |
$19.24 |
$19,239 |
D/D |
(1,000) |
35,730 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-12-03 |
4 |
OE |
$12.29 |
$12,290 |
D/D |
1,000 |
36,730 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2007-12-03 |
4 |
AS |
$19.03 |
$76,112 |
D/D |
(4,000) |
32,756 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2007-12-03 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
28,756 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-10-15 |
4 |
AS |
$23.49 |
$352,380 |
D/D |
(15,000) |
695,148 |
|
- |
|
801 Records found
|
|
Page 13 of 33 |
|
|
